SCHEMBL874193

SCHEMBL874193

CC=Cc1ccc(O)c(OC)c1CC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.40
CA1 P00915 2/20 0.38
CA2 P00918 1/20 0.38
ALOX5 P09917 4/20 0.36
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
PTPN1 P18031 2/20 0.35
CYP3A4 P08684 2/20 0.34
HMGCR P04035 1/20 0.34
APP P05067 1/20 0.33
MAPT P10636 1/20 0.33
CNR2 P34972 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
PPARG P37231 1/20 0.33
CA12 O43570 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
CA13 Q8N1Q1 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18035643 0.89 TYR (0.39) TYRCA1CA2ALOX5GABRA1
SCHEMBL26046430 0.87 TYR (0.40) TYRCA1CA2ALOX5GABRA1
SCHEMBL18035640 0.86 ALOX5 (0.44) TYRCA1CA2ALOX5GABRA1
SCHEMBL28660465 0.85 MAPT (0.36) CA1CA2PTPN1CYP3A4APP
SCHEMBL15914612 0.84 ALOX5 (0.50) TYRALOX5TRPV1
Cinnamaldehyde SCHEMBL29088467 0.83 ALDH1A1 (0.42) CA1CA2ALOX5CYP3A4APP
SCHEMBL31152022 0.81 SMPD1 (0.41) TYRCA1CA2ALOX5GABRA1
SCHEMBL1405663 0.81 KDM4E (0.46) CA1CA2PTPN1APPMAPT
SCHEMBL16681583 0.81 CYP3A4 (0.35) CYP3A4HMGCRLMNATP53TSHR
SCHEMBL1396832 0.81 CA1 (0.54) TYRCA1CA2PTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109776281-B Synthesis method of ethyl isoeugenol 南京林业大学 2020-10-13 CN claimed
EP-2621462-A1 ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR The Procter and Gamble Company (US) 2013-08-07 EP claimed
CN-103140209-A Oral care compositions with improved flavor PROCTER & GAMBLE 2013-06-05 CN claimed
WO-2012044728-A1 ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR THE PROCTER & GAMBLE COMPANY (US) 2012-04-05 WO claimed
US-20120082628-A1 Oral Care Compositions With Improved Flavor THE PROCTER & GAMBLE COMPANY 2012-04-05 US claimed
US-20070166341-A1 Solid volatile composition and method and system for making the same INTERNATIONAL ARTS & SCIENCE GROUP, INC. 2007-07-19 US claimed
JP-9249549-A None JP disclosed
JP-9241116-A None JP disclosed
JP-6287135-A None JP disclosed
US-20250302014-A1 WASP PEST MANAGEMENT SYSTEM TONER DARADH (IE) 2025-10-02 US disclosed
US-20250261684-A1 SMOKELESS TOBACCO PRODUCT FOR ORAL USE AND SOFT CAPSULE USED THEREIN SUNSHO PHARMACEUTICAL CO., LTD. (JP) 2025-08-21 US disclosed
US-20250120427-A1 CARYOPHYLLENE-CONTAINING COMPOSITION SUNSHO PHARMACEUTICAL CO., LTD. (JP) 2025-04-17 US disclosed
WO-2025070466-A1 SEAMLESS CAPSULE FOR ORAL CAVITY 森下仁丹株式会社 2025-04-03 WO disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed
EP-1561476-A1 DEODORANT COMPOSITION Takasago International Corporation (JP) 2005-08-10 EP disclosed
JP-H09249549-A COSMETIC COMPOSITION LION CORP 1997-09-22 JP disclosed
JP-H09241116-A COSMETIC COMPOSITION LION CORP 1997-09-16 JP disclosed
JP-H06287135-A EXTERNAL AGENT COMPOSITION FOR SKIN LION CORP 1994-10-11 JP disclosed
US-4154769-A Process for the production of 2-alkoxy-4-propen-1-yl-phenols HAARMANN & REIMER GMBH (DE) 1979-05-15 US disclosed
US-4071564-A Process for the production of 2-alkoxy-4-alkenyl phenols HAARMANN & REIMER GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1978-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120082628-A1 Oral Care Compositions With Improved Flavor TRPA1, TAS2R40, TAS2R30 TYR 278/4885CA1 2666/4885CA2 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.